Liposomal Nanomedicines: An Emerging Field

Abstract

Liposomal nanoparticles (LNs) encapsulating therapeutic agents, or liposomal nanomedicines (LNMs), represent one of the most advanced classes of drug delivery systems, with several currently on the market and many more in clinical trials. During the past 20 years, a variety of techniques have been developed for encapsulating both conventional drugs and the new genetic drugs (plasmid DNA-containing therapeutic genes, antisense oligonucleotides, and small, interfering RNA [siRNA]) within LNs encompassing a very specific set of properties: a diameter centered on 100 nm, a high drug-to-lipid ratio, excellent retention of the encapsulated drug, and a long (>6 hours) circulation lifetime. Particles with these properties tend to accumulate at sites of disease, such as tumors, where the endothelial layer is "leaky" and allows extravasation of particles with small diameters. Thus, LNs protect the drug during circulation, prevent it from reaching healthy tissues, and permit its accumulation at sites of disease. We will discuss recent advances in this field involving conventional anticancer drugs as well as gene-delivery, immunostimulatory, and gene-silencing applications involving the new genetic drugs. LNMs have the potential to offer new treatments in such areas as cancer therapy, vaccine development, and cholesterol management.

Liposomes in tissue engineering and regenerative medicine

“…Liposomes have different advantages when compared with other alternative carrier systems [29,30]. One of the main advantages is the fact that they are made of natural materials, i.e.…”

Biomateriais para formulações de base nanotecnológica visando terapia gênica ocular

“…Naturalmente, a eficácia de um sistema em exercer atividade biológica com baixa toxicidade não depende 20,21 Dessa maneira os lipossomas são capazes de incrementar a estabilidade dos ácidos nucleicos, diminuindo a sua hidrólise e consequentemente prolongando a sua capacidade de ação. 22 Nanoemulsões consistem em uma dispersão líquido-líquido de dois líquidos imiscíveis entre si e estabilizados por um surfactante, ou sistema surfactante, adequado. São sistemas que mesmo não sendo termodinamicamente estáveis apresentam elevada estabilidade cinética.…”

Combination Chemotherapy in Cancer: Principles, Evaluation and Drug Delivery Strategies

“…4) with considerable potential for delivery of therapeutic agents due to several features: biodegradability, biocompatibility, simplicity, scaled-up production, low inherent toxicity, weak immunogenicity, versatility in structure and in physicochemical properties (lipid composition, size and surface charge) and ability to undergo surface engineering towards conjugation of polymers and targeting ligands (Immordino et al, 2006;Hofheinz et al, 2005;Cattel et al, 2003). Due to those specific attributes, liposomes have the ability to modulate in vivo behavior (pharmacokinetics and biodistribution profile) and/or solubility properties of drugs and to protect them from premature degradation or inactivation after intravenous administration (Fenske et al, 2008;Immordino et al, 2006;Drummond et al, 1999;Allen, 1998). In general, when a drug is encapsulated within a carrier, such as liposome (Fig.…”